Regulatory

Foreign regulation and consumer sentiment may be pushing manufacturers away from titanium dioxide.

Ahead of Expo West 2024, TriNutra has announced a recent U.S. patent for the unique composition of its branded ingredients, ThymoQuin, B’utyQuin, and ThymoQuin-OCare.

According to Alkemist’s 2023 data, 47% of samples had levels of inorganic bromide above USP <561> limits.

This is an annual event in which industry stakeholders can meet with members of Congress and explain how public policies are impacting their businesses and consumers.

Scott Mazza breaks down the industry's top regulatory priorities related to CBD.

In this Q&A, experts look ahead at the opportunities and challenges the new year brings to contract manufacturing.

The joint venture between Cargill and dms-firmenich, called Avansya, has announced that EverSweet stevia sweetener has received a positive safety opinion from the European Food Safety Authority and the UK Food Standards Agency.

Curcumin C3 Reduct has earned approval by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list, which allows the product to be introduced and commercialized in food and supplements in Brazil.

According to Ethical Naturals, the approval was the result of 18 months of work by the company and Transchem, its Australian partner and exclusive distributor of AlphaWave in the country.

Nutritional Outlook’s Editorial Advisory Board members highlight potential challenges for the nutraceutical, natural product, and health and wellness industries in 2024.

California Assembly Bill 82, which bans the sale of weight management and muscle building supplements to minors, has been advanced by the Committee on Health.

Nutritional Outlook’s Editorial Advisory Board shares its predictions and tips for success in 2024.

The product is an all-natural, plant-based ingredient that can replace starches, gums, phosphates, and carrageenan, as well as enhance juiciness, flavor, and the texture of meat products.

The GlyCare 3FL 9OO1 ingredient is now approved in the EU at a higher usage level compared to other 3-FL ingredients, the company says.

The network is called Green Bridge Gateway and aims to help companies overcome hurdles of entering the UK and EU cannabinoid markets.

The claims focus on support for immune and digestive health.

The response advised Nammex that FDA has not come to a decision in the required 180 days “due to competing agency priorities,” but that the staff is evaluating the petition.

The Dr. Teal’s line of adult and kids’ melatonin-containing topical products includes a body scrub, bath soak, and moisturizer.

The Council for Responsible Nutrition-International (CRN-I) has announced the publication of a report summarizing the proceedings of its annual Scientific Symposium in Düsseldorf, Germany.

This means that the ingredient can be used in Brazil to fortify food and beverage products. Prior to food and beverage approval, the ingredient received ANVISA approval for retail supplement use in 2020.

Also, what to watch in 2024.

The complaint aims to have the legislation declared unconstitutional and seeks an injunctive order restraining the Attorney General’s Office from enforcing the state law.

Open Book Extracts is joined by BayMedica, Charlotte's Web, Hemp Beverage Alliance, Kazmira, Mad Tasty, and WYLD, among many others, in joining One Hemp.

The farm grows seven of the company’s ingredients: Rhodiola rosea, feverfew, nettle, flaxseed, valerian, Rhapontici radix, and lemon balm.

The Council for Responsible Nutrition has issued a statement in response to a recent research letter that the organization says raises unnecessary alarm about the pediatric use of melatonin.

TriNutra announced that its ThymoQuin ingredient has now been approved as a novel food/dietary supplement by the Thailand Food and Drug Administration.

Supplements sold in Korea containing myHMB can now make product claims about improving exercise performance.

The Council for Responsible Nutrition has announced receipt of an interim response from the U.S. Food and Drug Administration (FDA) to the Council’s recent citizen petition requesting that the agency change the way it applies the drug preclusion clause to the Food, Drug, and Cosmetic Act (FD&C Act).